Financial Markets collage Northcote Internet Logo
transparent spacer
transparent spacer
 >   > 
transparent spacer
 
curve on page transparent spacer
Northcote Internet Ltd provide Investor Relations Webcasting. Click Here
 
transparent spacer transparent spacer transparent spacer transparent spacer
transparent spacer Home menu end curves
Newsletter
transparent spacer
transparent spacer About Us menu end curves
transparent spacer
transparent spacer Donations menu end curves
transparent spacer
transparent spacer Registrars menu end curves
transparent spacer
transparent spacer Spread Betting menu end curves
transparent spacer
transparent spacer Submit links menu end curves
transparent spacer
transparent spacer transparent spacer
transparent spacer transparent spacer transparent spacer
transparent spacer
transparent spacer
navigation curves Home navigation curves navigation curves By Index navigation curves navigation curves By Sector navigation curves navigation curves Alphabetically navigation curves navigation curves Search navigation curves navigation curves My Portfolio navigation curves
 >  > 
 
Follow northcote_b on Twitter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
 
Antisoma plc
transparent spacer
transparent spacer
transparent spacer
Company Information
Address: Mitre House
160 Aldersgate Street
London
EC1A 4DD
Index: FTSE Fledgling
FTSE TechMark Focus
FTSE TechMark All Share
FTSE TechMark Mediscience
Tel: +44(0) 207 099 7268 Sector: Pharmaceuticals
Fax:
E-Mail: info@antisoma.com Epic: ASM
Secretary: Christopher Hill    
Registrar: Neville Registrars Ltd Updated: 8/05/2013

Company Overview

The principal activity of the Company is the investment in and growth and development of businesses which present opportunities for value creation.
The Directors of Antisoma intend to identify investment opportunities offering the potential to deliver a favourable return to shareholders over the medium term, primarily in the form of a capital gain. A particular consideration will be to identify businesses which, in the opinion of the Directors, are under-performing and present opportunities for value creation. The Company's equity interest in a potential investment may range from a minority position to 100 per cent. ownership and the interest may be either quoted or unquoted.

 
Annual Reports
Description Report Date Published Current  
bullet point Annual Report 2012 in PDF 30/06/2012 1/10/2012 Yes  
bullet point Annual Report 2011 in PDF 30/06/2011 26/07/2011 No  
bullet point Annual Report 2010 in PDF 30/06/2010 5/08/2010 No  
bullet point Annual Report 2009 in PDF 30/06/2009 24/09/2009 No  
bullet point Annual Report 2008 in PDF 30/06/2008 26/09/2008 No  
bullet point Annual Report 2007 in PDF 30/06/2007 11/09/2007 No  
bullet point Annual Report 2005 in PDF (0.97Mb) 30/06/2005 13/09/2005 No  
 
Interim Reports
Description Report Date Published Current  
bullet point Interim Results 2012 in PDF 31/12/2012 19/02/2013 Yes  
bullet point Interim Results 2011 in PDF 31/12/2011 22/03/2012 No  
bullet point Interim Results 2010 in PDF 31/12/2010 8/02/2011 No  
bullet point Interim Results 2009 in PDF 31/12/2009 17/02/2010 No  
bullet point Interim Results 2008 in PDF 31/12/2008 16/02/2009 No  
bullet point Interim Results 2007 in PDF 31/12/2007 21/02/2008 No  
bullet point Interim Results 2006 in PDF 31/12/2006 15/02/2007 No  
 
Other Links
Description
bullet point Home
bullet point Investor Relations
bullet point Results Index
bullet point Contacts


transparent spacer